BioPorto A/S: Financial Calendar 2018

February 8, 2018  Quiet period prior to the annual report begins (4 weeks) 
March 2, 2018     Deadline for shareholder proposals for the AGM           
March 8, 2018     Annual report for 2017                                   
April 13, 2018    Annual General Meeting                                   
April 19, 2018    Quiet period prior to the Interim report begins (2 weeks)
May 3, 2018       Interim report - 3 months 2018                           
August 2, 2018    Quiet period prior to the Interim report begins (2 weeks)
August 16, 2018   Interim report - 6 months 2018                           
October 25, 2018  Quiet period prior to the Interim report begins (2 weeks)
November 8, 2018  Interim report - 9 months 2018                           

For further information, please contact:

Gry Husby Larsen, General Counsel

Peter M. Eriksen, CEO

Telephone [phone], e-mail [e-mail]

About BioPorto

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides
healthcare professionals in clinical and research settings a range of
diagnostic tests and antibodies. Our pioneering product portfolio includes
assays for underserved disease states such as NGAL for acute kidney injury.
BioPorto has its headquarters in Copenhagen, Denmark and is listed on the
Nasdaq Copenhagen stock exchange.

Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=656612